Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection. (Record no. 24020171)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02028 a2200649 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516223458.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201408s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1538-3598 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1001/jama.2014.7734 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Sulkowski, Mark S |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20140804 |
| 245 00 - TITLE STATEMENT | |
| Title | Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | JAMA |
| Date of publication, distribution, etc. | |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 353-61 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Administration, Oral |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antiviral Agents |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Coinfection |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Administration Schedule |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Therapy, Combination |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Genotype |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV Infections |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepacivirus |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepatitis C |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | RNA, Viral |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ribavirin |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sofosbuvir |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Uridine Monophosphate |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Viral Load |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Naggie, Susanna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lalezari, Jacob |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fessel, Walford Jeffrey |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mounzer, Karam |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shuhart, Margaret |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Luetkemeyer, Anne F |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Asmuth, David |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gaggar, Anuj |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ni, Liyun |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Svarovskaia, Evguenia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Brainard, Diana M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Symonds, William T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Subramanian, G Mani |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | McHutchison, John G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rodriguez-Torres, Maribel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dieterich, Douglas |
| 773 0# - HOST ITEM ENTRY | |
| Title | JAMA |
| Related parts | vol. 312 |
| -- | no. 4 |
| -- | p. 353-61 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1001/jama.2014.7734">https://doi.org/10.1001/jama.2014.7734</a> |
| Public note | Available from publisher's website |
No items available.